Extracorporeal photochemotherapy for Epstein-Barr virus-associated lymphoma after lung transplantation

Transplantation

Volumn 68, Issue 7, 1999, Pages 1056-1058

  Schoch, O D ^a   Boehler, A ^a   Speich, R ^a   Nestle, F O ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; THYMOCYTE ANTIBODY; VALACICLOVIR;

ADOLESCENT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EPSTEIN BARR VIRUS; FEMALE; GRAFT REJECTION; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; LYMPHOMA; ORAL DRUG ADMINISTRATION; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL;

ADOLESCENT; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GRAFT REJECTION; HERPESVIRUS 4, HUMAN; HUMANS; LUNG TRANSPLANTATION; LYMPHOMA, NON-HODGKIN; PHOTOPHERESIS;

EID: 0033569941     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199910150-00027     Document Type: Article

References (19)

1. Armitage JM, Kormos RL, Stuart RS, et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 1991; 10: 877.
2. Boyle GJ, Michaels MG, Webber SA, et al. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients. J Pediatr 1997; 131: 309.
3. Axis RM, Maia DM, Neuringer IP, et al. Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naive lung transplant recipient. Am J Respir Crit Care Med 1996; 154: 1712.
4. Darenkov IA, Marcarelli MA, Basadonna GP, et al. Reduced incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder using preemptive antiviral therapy. Transplantation 1997; 64(6): 848.
5. Maurer JR, Tewari S. Nonpulmonary medical complications in the intermediate and long-term survivor. Clin Chest Med 1997; 18(2): 367. In: Maurer JR, ed. Surgical approaches to end-stage disease: lung transplantation and volume reduction. Philadelphia: Saunders, 1997.
6. Maurer JR, Tewari S. Nonpulmonary medical complications in the intermediate and long-term survivor. Clin Chest Med 1997; 18(2): 367. In: Maurer JR, ed. Surgical approaches to end-stage disease: lung transplantation and volume reduction. Philadelphia: Saunders, 1997.
7. Barr ML, Meiser BM, Eisen HJ, et al. Photopheresis for the prevention of rejection in cardiac transplantation. N Engl J Med 1998; 339: 1744.
8. Meiser BM, Kur F, Reichenspurner H, et al. Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation. Transplantation 1994; 57: 563.
9. Slovis BS, Loyd JE, King LE Jr. Photopheresis for chronic rejection of lung allografts [Letter]. N Engl J Med 1995; 332: 962.
10. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996: 15: 1.
11. Blay JY, Burdin N, Rousset F, et al. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood 1993; 82: 2169.
12. Edelson R, Berger C, Gasparro F, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1987; 316: 297.
13. Krasagakis K, Dippel E, Ramaker J, Owsianowski M, Orfanos CE. Management of severe scleroderma with long-term extra-corporeal photopheresis. Dermatology 1998; 196(3): 309.
14. Owsianowski M, Gollnick H, Siegert W, Schwerdtfeger R, Orfanos CE. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant 1994; 14; 845.
15. Holbrook MR, Powell RJ. Is there a future for extracorporeal photochemotherapy in the treatment of rheumatological diseases? Ann Rheumat Dis 1997; 56(6): 339.
16. Van Iperen HP, Beijersbergen van Henegouwen GMJ. Photopheresis, a possible therapy for airway hyperreactivity? J Photochem Photobiol B 1996; 1997: 228.
17. Di Renzo M, Rubegni P, De Aloe G, et al. Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma. Immunology 1997; 92: 99.
18. Miracco C, Rubegni P, De Aloe G, et al. Extracorporeal chemotherapy induces apoptosis of infiltrating lymphoid cells in patients with mycosis fungoides in early stages. A quantitative histological study. Br J Dermatol 1997; 137: 549.
19. Aringer M, Graninger WB, Smolen JS, et al. Photopheresis treatment enhances CD95 (FAS) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis. Br J Rheumatol 1997; 36: 1276.